Abstract
Background: Distant metastases are the strongest predictor of poor prognosis in patients with small intestinal neuroendocrine tumors (siNETs). Cytoreductive hepatectomy can improve survival in patients with liver metastases, but the benefit of cytoreductive hepatectomy in patients with extrahepatic metastases is debated and whether to proceed with hepatectomy when peritoneal metastases are encountered intraoperatively is controversial. In this study, we evaluated survival outcomes in patients with liver and peritoneal metastases who underwent cytoreductive hepatectomy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: HPB : the official journal of the International Hepato Pancreato Biliary Association
Paper Title
Journal
Date
